Herbas VPB

Print
EN | LT
LT - CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS
EN - CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4439 (2006.01)
A61K 45/06 (2013.01)
A61K 31/506 (2006.01)
A61K 31/4184 (2013.01)
A61K 31/519 (2006.01)
A61K 31/437 (2013.01)
A61K 31/437 (2006.01)
A61K 31/506 (2013.01)
A61K 31/337 (2006.01)
A61K 31/519 (2013.01)
A61P 35/00 (2006.01)
A61K 31/4439 (2013.01)
A61K 31/337 (2013.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3082779
(13) Kind of document T
(96) European patent application number 14871217.7
Date of filing the European patent application 2014-12-19
(97) Date of publication of the European application 2016-10-26
(45) Date of publication and mention of the grant of the patent 2023-06-07
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/071724
Date 2014-12-19
PCT application publication
(87) Number WO 2015/095825
Date 2015-06-25
Priority applications
(30) Number Date Country code
201361919625 P 2013-12-20 US
Inventors
(72)
SAHA, Saurabh , US
WELSCH, Dean , US
DECRESCENZO, Gary , US
ROIX, Jeffrey James , GB
Grantee
(73) Biomed Valley Discoveries, Inc. , 4435 Main Street Suite 550, Kansas City, Missouri 64111, US
Title
(54) CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS
  CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS